New study downplays danger of birth defects from methotrexate

12/30/2004 | Reuters

French researchers say the risk of birth defects from the drug methotrexate may not be as great as previously believed. High doses of methotrexate can induce abortion, but it also is used in low doses to treat rheumatoid arthritis and other conditions. Previous studies have indicated birth defects could occur among children born to women taking even low doses of the drug.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ